The popularity of Sildenafil initially drove a surge for pharma, however recent changes present a uncertain picture for investors. Lower-cost alternatives are reducing revenue, and persistent patent challenges add https://albiecjvi068904.ampblogs.com/viagra-and-pharma-a-precarious-bet-78080693